EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 173 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $966,000 | +4.3% | 20,125 | 0.0% | 0.06% | -14.5% |
| Q1 2020 | $926,000 | -23.7% | 20,125 | -0.3% | 0.08% | +7.0% |
| Q4 2019 | $1,213,000 | +6.2% | 20,185 | 0.0% | 0.07% | +1.4% |
| Q3 2019 | $1,142,000 | +1.6% | 20,185 | 0.0% | 0.07% | 0.0% |
| Q2 2019 | $1,124,000 | +170.8% | 20,185 | +145.6% | 0.07% | +180.0% |
| Q1 2019 | $415,000 | +25.4% | 8,220 | 0.0% | 0.02% | +8.7% |
| Q4 2018 | $331,000 | -41.9% | 8,220 | 0.0% | 0.02% | -34.3% |
| Q3 2018 | $570,000 | -8.4% | 8,220 | 0.0% | 0.04% | -16.7% |
| Q2 2018 | $622,000 | +43.6% | 8,220 | 0.0% | 0.04% | +40.0% |
| Q1 2018 | $433,000 | – | 8,220 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |